Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children
Key facts
- Who runs it
- Fujian Provincial Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 324 people enrolled
- Started
- 22 May 2024
- Ended
- 21 Oct 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexmedetomidine Hydrochloride
- Midazolam
- normal Saline
- Glucose solution
- Record updated
- 30 July 2026
Who can take part
- Age
- 2 years to 5 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- ASA physical status I or II
- Aged 2-5 years
- Scheduled for elective tonsillectomy and (or) adenoidectomy
Who cannot take part
- Intake of sedative or analgesic medication within 48 hours before surgery
- Major life changes 1 month before the operation, such as the divorce of parents, death of parents, moving to a new home, changing to a new kindergarten, etc
- Allergy to study drugs
- Any other conditions that precluded study inclusion
- Parents refusing to allow their children to participate
- Developmental delay
- Psychosis
- Body mass index > 30 kg/m2
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn the effect of dexmedetomidine premedication in postoperative negative behavior changes in children compared to midazolam premedication. It will also learn about the effect of dexmedetomidine and midazolam in emergence delirium. The main questions are:
Read full original descriptionShow less
* Dose dexmedetomidine lower the incidence of postoperative negative behavior changes compared to midazolam? * Dose dexmedetomidine lower the incidence of emergence delirium compared to midazolam? Researchers will compare dexmedetomidine to midazolam (a common pediatric premedication) to see if dexmedetomidine works to treat postoperative negative behavior change and emergence delirium.
Participants will:
* Take intranasal dexmedetomidine or oral midazolam or placebo (a look-alike substance that contains no drug) premedication * Fill in the Post hospitalization behavior questionnaire for ambulatory surgery postoperative 1, 3, 7, and 30
The 3 groups in the trial
- Dexmedetomidine groupTreatment being tested
Participants were premedicated with intranasal dexmedetomidine 2 μg/kg and oral sweet solution 0.25 mL/kg.
Treatment: Dexmedetomidine Hydrochloride and Glucose solution
- Midazolam groupExisting treatment, for comparison
Participants were premedicated with intranasal 0.9% saline 0.02 mL/kg and oral midazolam 0.5 mg/kg.
Treatment: Midazolam and normal Saline
- Placebo groupPlacebo, for comparison
Participants were premedicated with intranasal 0.9% saline 0.02 mL/kg and oral sweet solution 0.25 mL/kg.
Treatment: normal Saline and Glucose solution
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intranasal Dexmedetomidine Versus Oral Midazolam Premedication for Postoperative Negative Behavior Changes in Children: A Randomized Controlled Trial
- Record updated
- 30 July 2026